Claim Missing Document
Check
Articles

Found 4 Documents
Search

Uveitic Glaucoma in Recurrent Anterior Uveitic Patient Santoso, Giovanni Adrian; Wibawaty, Halida; Fairuzia, Amania
Oftalmologi : Jurnal Kesehatan Mata Indonesia Vol 4 No 3 (2022): Jurnal Oftalmologi
Publisher : Pusat Mata Nasional Rumah Sakit Mata Cicendo Bandung

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.11594/ojkmi.v4i3.39

Abstract

Introduction: Uveitic glaucoma is a serious disorders that can damage optic nerve and visual field permanently. Management of the disease requires careful diagnosis and adequate control of both IOP and inflammation. A multidisciplinary approach is necessary to achieve a desired outcome. Case Report: A case of a 45-year-old female patient who presented witha chief complaint of red, blurry vision, and dicomfort in the right eye since 1 weeks prior. There was a history of reccurent ante- rior uveiticonthe right eye since 2 years ago. She regularly takes corticosteroid based on the doctor’s advice. Intraocular pressure (IOP) on the right eye was 49 mmHg. This patient underwent trabeculec- tomy + 5-FU without any complications. IOP on the right eye is 16 mmHg postoperative and stable on the next follow up. Visual acuity of the right eye is 0.2F2 because of posterior subcapsular cataract (PSC). Immunomodulator medication was given under internist supervision. Conclusion: Uveitic glaucoma is a complex condition. Appropriate examinations are necessary to prevent further complications. Surgery is needed for patient who doesn’t respond well to anti- glaucoma medical therapy. Observation of postoperative inflammation with topical cortisteroid or oral administration has an important effect in surgical wound recovery. Continuing medication and educa- tion play an important role for long-term visual acuity.
UNRESOLVED QUESTIONS ABOUT COATS DISEASE: A CASE REPORT: Poster Presentation - Case Report - General practitioner Ardityastiti, Khairani Azizah; Wibawaty, Halida
Majalah Oftalmologi Indonesia Vol 49 No S2 (2023): Supplement Edition
Publisher : The Indonesian Ophthalmologists Association (IOA, Perhimpunan Dokter Spesialis Mata Indonesia (Perdami))

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35749/waewgy15

Abstract

UNRESOLVED QUESTIONS ABOUT COATS DISEASE: A CASE REPORT: Poster Presentation - Case Report - General practitioner Ardityastiti, Khairani Azizah; Wibawaty, Halida
Majalah Oftalmologi Indonesia Vol 49 No S2 (2023): Supplement Edition
Publisher : The Indonesian Ophthalmologists Association (IOA, Perhimpunan Dokter Spesialis Mata Indonesia (Perdami))

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35749/1ntvcb33

Abstract

Introduction : Coats disease (CD) is an idiopathic retinal vascular disorder accompanied by retinal telangiectasia with intraretinal and/or subretinal exudation without appreciable retinal or vitreal traction. The disease most common in young males and unilateral involvement. The etiopathogenesis of CD is unclear. However, previous studies have reported changes in inflammatory cytokines, and levels of VEGF in aqueous humor are also higher in patients with CD. Case Illustration : We reported a 19-year-old man with complaints of decreased vision, floaters, and uncomfortable feelings in his RE, since one year before presentation. Initial examination showed visual acuity of the RE was 0.5F2 and the LE was 1.0. Examination of posterior segment showed irregularly-dilated telangiectatic vessels and exudative RD. We performed an OCT examination in both eyes and the results showed extensive cystoid macular edema in the RE. Ultrasonography of the RE also showed an exudative RD. The patient was diagnosed with Coats disease grade 3 and planned to receive intravitreal anti-VEGF injection in RE. After the second injection, OCT examination results showed no improvement in the patient's eye condition. Until now, we’re still trying to find a suitable therapy and considering laser photocoagulation. Discussion : Previous studies showed that there was an improvement in some CD patients only with anti-VEGF injections, but some other patients didn’t improve and had to get other additional therapy with laser photocoagulation/cryotherapy. It’s related to the severity of the disease, where a disease with grade ?3, tends to require combination therapy with laser photocoagulation/cryotherapy. Conclusion : Intravitreal anti-VEGF injections alone don’t show improvement in CD grade?3.
A SUCCESSFUL TREATMENT OF INTRAVITREAL MOXIFLOXACIN INJECTION IN ACUTE POST-CATARACT SURGERY ENDOPHTHALMITIS: A CASE REPORT: Poster Presentation - Case Report - General practitioner Ardityastiti, Khairani Azizah; Wibawaty, Halida
Majalah Oftalmologi Indonesia Vol 49 No S2 (2023): Supplement Edition
Publisher : The Indonesian Ophthalmologists Association (IOA, Perhimpunan Dokter Spesialis Mata Indonesia (Perdami))

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35749/qqedxk93

Abstract

Introduction : Endophthalmitis is a severe form of ocular inflammation and one of the most dreaded cataract surgery complications which may lead to loss of vision. Post-cataract surgery endophthalmitis is a serious complication that occurs when infecting organisms invade the posterior segment of the eye during the time of surgery. Currently, intravitreal injection of vancomycin along with ceftazidime is the first-line treatment, but another study showed a good result of intravitreal moxifloxacin injection in patients with Postoperative endophthalmitis. Case Illustration : We reported a 59-year-old woman presented with blurred vision, redness, and pain in the left eye 4 days after phacoemulsification. Visual acuity of LE was hand movement and anterior segment examination found that there was a conjunctival and pericorneal injection, corneal edema, cells, and anterior chamber fibrin formation. Ultrasonography examination showed severe levels of debris in the vitreous humor. Patient was diagnosed with acute post-cataract surgery endophthalmitis and received an intravitreal moxifloxacin injection. Fortunately, one week after that injection, there wasa good result in the patient’s eye condition. Visual acuity of LE improved to 0,1 and the patient planned to receive the second moxifloxacin injection to get the best possible results. Discussion : Moxifloxacin expresses broad-spectrum microbial coverage with a very good diffusion and low adverse effects. Moxifloxacin also has a better penetration ability into inflamed ocular tissue than all other antibiotics. Based on that, other studies said that intravitreal moxifloxacin can replace vancomycin and ceftazidime combinations for the treatment of ocular infections. Conclusion : Intravitreal moxifloxacin injections have a good result in acute post-cataract surgery endophthalmitis.